NVO vs ABBV — Performance Comparison
Side-by-side percent change for Novo Nordisk A/S (NVO), AbbVie Inc. (ABBV) across every preset interval.
Over the past year, ABBV is up 15.31% versus NVO down 32.78% — ABBV ahead by 48.09%. Over the past 30 days, NVO is up 8.96% and ABBV is up 0.52%. NVO trades at $44.47; ABBV at $209.50.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk A/S | $44.47 | -2.91% | -5.39% | -3.48% | +8.96% ★ | -10.30% | -12.61% | -7.86% ★ | -32.78% | -46.96% | +10.36% |
| ABBV AbbVie Inc. | $209.50 | -0.60% ★ | +0.79% ★ | +3.94% ★ | +0.52% | -9.50% ★ | -8.31% ★ | -9.84% | +15.31% ★ | +46.21% ★ | +79.23% ★ |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
NVONovo Nordisk A/S
$44.47-2.91% today
ABBVAbbVie Inc.
$209.50-0.60% today